Hepatitis B News and Research

Latest Hepatitis B News and Research

HCV patients treated with DAA therapy not at increased risk of developing liver cancer, study finds

A new study presented this week at The Liver Meeting — held by the American Association for the Study of Liver Diseases — found patients with hepatitis C who take direct-acting antiviral medication are at no higher risk for developing liver cancer than those who do not take the medication.

11 Nov 2016

Particular eating behaviors linked to lower odds of developing liver diseases

Particular eating behaviors may lower the risk of developing non-alcoholic fatty liver disease (NAFLD), according to research presented this week at The Liver Meeting — held by the American Association for the Study of Liver Diseases.

11 Nov 2016

New technology uses USB stick to monitor HIV in bloodstream

The device, created by scientists at Imperial College London and DNA Electronics, uses a drop of blood to detect HIV, and then creates an electrical signal that can be read by a computer, laptop or handheld device.

10 Nov 2016

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Amgen today announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for the expanded use of ENBREL (etanercept), making it the first and only systemic therapy to treat pediatric patients (ages 4-17) with chronic moderate-to-severe plaque psoriasis.

7 Nov 2016

TSRI researchers uncover mechanism behind T cell exhaustion

In a new study with broad implications for treating cancers and chronic viral infections, scientists at The Scripps Research Institute (TSRI) have uncovered a mechanism behind a phenomenon called “T cell exhaustion.”

2 Nov 2016

Two genes linked to increase in immunity to hepatitis C after childbirth, study shows

Alternative forms of two genes are associated with a boost in immunity to hepatitis C after childbirth, a study led by a Nationwide Children's Hospital physician-researcher shows.

31 Oct 2016

Over 1 million people treated with revolutionary hepatitis C medicines

Over one million people in low- and middle-income countries have been treated with a revolutionary new cure for hepatitis C since its introduction two years ago.

27 Oct 2016

Poor, remote Indigenous Australians have increased risk of sexually transmissible infections

A unique 21-year study of more than 2.4 million cases of infectious disease across Australia reveals a major social divide where being poorer, living remotely or being an Indigenous Australian means having an increased risk of sexually transmissible infections (STIs).

25 Oct 2016

GAFFI: Access to rapid diagnostics, antifungals could prevent over a million AIDS-related deaths by 2020

Fungal infection causes around half of AIDS-related deaths, of which there were 1,100,000 in 2015. A first of its kind analysis – ‘Modelling reduction in AIDS deaths’ by the University of Manchester’s Professor David W Denning and published today in Philosophical Transactions of the Royal Society B – suggests that the opportunity to save lives is being missed.

25 Oct 2016

TSRI scientists discover reason for lack of successful HCV vaccine design

Researchers have been trying for decades to develop a vaccine against the globally endemic hepatitis C virus (HCV). Now scientists at The Scripps Research Institute have discovered one reason why success has so far been elusive.

24 Oct 2016

Scientists discover new mechanism for inadequate immune defense against chronic viral infection

Scientists at the University of Basel discovered a fundamental new mechanism explaining the inadequate immune defense against chronic viral infection. These results may open up new avenues for vaccine development. They have been published in the journal "Science Immunology".

21 Oct 2016

New study raises serious safety concerns in clinical use of caspase inhibitors for liver injury

Many acute and chronic liver diseases, including alcoholic hepatitis, result from apoptotic (programmed) cell death mediated by the enzyme caspase.

20 Oct 2016

Wyss Institute wins 'Best of What's New' award for paper-based rapid Zika test

A rapid Zika test, developed by an international, multi-institutional team of researchers led by synthetic biologist James Collins, Ph.D., at Harvard University's Wyss Institute for Biologically Inspired Engineering, has today been named a 2016 "Best of What's New" awards winner by Popular Science magazine in the Health category.

20 Oct 2016

Many Canadian territories restrict access to medications for treating hepatitis C, study finds

A study conducted by Canadian and Australian researchers shows that nearly everywhere in Canada, the provinces and territories impose obstacles to reimbursement of new direct-acting antivirals (DAA) to treat hepatitis C by because of their cost.

14 Oct 2016

Japanese researchers identify mechanism for hormone that limits liver fibrosis

Nonalcoholic steatohepatitis (NASH) has been emerging worldwide and effective treatment, especially for liver fibrosis, is essential for improving the prognosis.

13 Oct 2016

Community outreach workers may help increase HBV vaccination rates to cut risk of liver cancer

Liver cancer is more common among Asian Americans in part because they are at high risk of HBV infection.

12 Oct 2016

Research findings provide new avenues to target virus infection

Viral infection is one of the leading medical challenges of the 21st Century, ranging from the Hepatitis C Virus (HCV) epidemic affecting 3% of the global population, to recent outbreaks of West Nile, Zika, and Ebola viruses.

12 Oct 2016

Parents do not perceive need to vaccinate children against influenza, study finds

Despite the fact that influenza leads to more hospitalizations and deaths among children than any other vaccine-preventable disease, parents frequently decline vaccinating their children against influenza because they don't perceive the need, according to a new case-control study published in the October issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology.

30 Sep 2016

MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

Hepatitis B (HBV) is a viral infection that increases the likelihood of developing liver cancer or liver failure.

26 Sep 2016

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis announced today that the US Food and Drug Administration has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes.

24 Sep 2016

Hepatitis B News and Research

Latest Hepatitis B News and Research

HCV patients treated with DAA therapy not at increased risk of developing liver cancer, study finds

Particular eating behaviors linked to lower odds of developing liver diseases

New technology uses USB stick to monitor HIV in bloodstream

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

TSRI researchers uncover mechanism behind T cell exhaustion

Two genes linked to increase in immunity to hepatitis C after childbirth, study shows

Over 1 million people treated with revolutionary hepatitis C medicines

Poor, remote Indigenous Australians have increased risk of sexually transmissible infections

GAFFI: Access to rapid diagnostics, antifungals could prevent over a million AIDS-related deaths by 2020

TSRI scientists discover reason for lack of successful HCV vaccine design

Scientists discover new mechanism for inadequate immune defense against chronic viral infection

New study raises serious safety concerns in clinical use of caspase inhibitors for liver injury

Wyss Institute wins 'Best of What's New' award for paper-based rapid Zika test

Many Canadian territories restrict access to medications for treating hepatitis C, study finds

Japanese researchers identify mechanism for hormone that limits liver fibrosis

Community outreach workers may help increase HBV vaccination rates to cut risk of liver cancer

Research findings provide new avenues to target virus infection

Parents do not perceive need to vaccinate children against influenza, study finds

MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Hepatitis B News and Research

Latest Hepatitis B News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in